Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes

Diabetic Medicine - Tập 24 Số 12 - Trang 1329-1335 - 2007
Hiroki Yokoyama1, Yuuya Yokota1, J Tada1, Sakiko Kanno1
1Jiyugaoka Medical Clinic, Internal Medicine, Obihiro, Japan

Tóm tắt

AbstractAims  Interaction of vascular and metabolic factors appears to contribute to the pathogenesis of diabetic neuropathy. The aim of the study was to assess the impact of arterial stiffening and thickness on diabetic neuropathy in Type 2 diabetes.Methods  In 294 patients with Type 2 diabetes, neuropathy was assessed by four components: the presence of neuropathic symptoms, the absence of ankle tendon reflexes, perception of vibration scores and heart rate variation. We measured intima‐media thickness (IMT) of carotid arteries to assess arterial thickening, and brachial–ankle pulse‐wave velocity (PWV) and brachial pulse pressure (PP) which reflect arterial stiffening.Results  Diabetic neuropathy, defined as ≥ two of the four components, was significantly associated with age, duration, glycated haemoglobin (HbA1c), systolic blood pressure, diastolic blood pressure, PP, hypertension, retinopathy, urinary albumin excretion rate, nephropathy stages, PWV and IMT. PWV and PP were significantly associated with neuropathy independent of conventional cardiovascular risk factors. Multiple logistic regression analysis revealed that PWV, retinopathy, age, and HbA1c, were significant independent determinants of neuropathy.Conclusions  The present cross‐sectional study indicates that markers for vascular wall properties such as PWV, IMT and PP are significantly associated with diabetic neuropathy. PWV and PP are significant determinants of neuropathy independent of conventional cardiovascular risk factors. Multifactorial intervention to inhibit progression of the atherosclerotic process may slow progression of neuropathy.

Từ khóa


Tài liệu tham khảo

10.1002/dmr.5610030206

10.1007/s001250051477

10.1007/s001250051062

10.1016/S0895-4356(99)00170-5

10.1007/s001250100001

10.1056/NEJMoa032782

Maser RE, 1989, Epidemiological correlates of diabetic neuropathy: report from the Pittsburgh Epidemiology of Diabetes Complications Study, Diabetes, 38, 1456, 10.2337/diab.38.11.1456

10.1161/01.STR.23.12.1752

10.1161/01.CIR.96.5.1432

10.1161/01.STR.32.2.454

10.1161/01.CIR.0000033824.02722.F7

10.1161/CIRCULATIONAHA.105.579342

10.1291/hypres.26.615

10.1111/j.1523-1755.2004.00752.x

10.1016/j.diabres.2006.06.015

10.1681/ASN.2004090769

10.1161/01.HYP.0000158268.95012.08

10.1016/j.amjhyper.2005.12.009

Hotta N, 1994, Use of the C64 quantitative tuning fork and the effect of niceritol in diabetic neuropathy, Clin Ther, 16, 1007

10.2165/00044011-200424110-00006

10.2337/diacare.17.10.1172

10.2337/diacare.22.9.1479

10.1007/BF00400697

10.1007/s001250051310

10.1007/s00125-004-1617-y

10.1001/archinte.1997.00440340025002

10.1007/BF00285287

10.2337/diacare.26.5.1553

10.1161/01.STR.27.8.1316

10.1007/s00125-006-0368-3

10.2337/diacare.17.6.578

10.2337/diacare.29.02.06.dc05-1242

10.2337/diacare.27.4.972

10.2337/diacare.23.9.1369

10.1111/j.1464-5491.1991.tb01563.x

10.1161/01.STR.30.3.550

10.1097/00004872-200212000-00002

10.1007/s10286-006-0345-4

10.1161/01.STR.0000236632.58323.cd

10.1056/NEJMoa021778

10.2337/dc05-2370

10.1161/hc3801.097806

Thông tin
Thông tin xuất bản

Diabetic Medicine

Tập 24 Số 12

1329-1335

Thông tin tác giả